An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents

Similar Works

Action	Title	Year	Authors
+ PDF Chat	Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee	2014	Channing J. Paller Penelope A. Bradbury S. Percy Ivy Lesley Seymour Patricia LoRusso Laurence H. Baker Larry Rubinstein Erich Huang Deborah Collyar Susan Groshen
+ PDF Chat	Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies	2022	Shu Wang Elias Sayour Ji‐Hyun Lee
+ PDF Chat	Seamless Phase I-II Trial Design for Assessing Toxicity and Efficacy for Targeted Agents	2010	Antje Hoering Mike LeBlanc John Crowley
+ PDF Chat	Phase I Drug Combination Trial Design: Walking the Tightrope	2009	Paul Hamberg Jaap Verweij
+	Challenges and Innovations in Phase I Dose-Finding Designs for Molecularly Targeted Agents and Cancer Immunotherapies	2016	Jun Yin Shihao Shen
+	Designs of drug-combination phase I trials in oncology: a systematic review of the literature	2014	Marie-Karelle Rivière Christophe Le Tourneau Xavier Paolettí Frédéric Dubois Sarah Zohar
+	A Simulation Study Evaluating Phase I Clinical Trial Designs for Combinational Agents.	2021	Shu Wang Ji‐Hyun Lee
+	Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents	2018	Akihiro Hirakawa Hiroyuki Sato Takashi Daimon Shigeyuki Matsui
+	Phase I Trial Design and Methodology for Anticancer Drugs	2004	Patrick V. Acevedo Deborah Toppmeyer Eric H. Rubin
+ PDF Chat	Practical designs for Phase I combination studies in oncology	2016	Nolan A. Wages Anastasia Ivanova Olga Marchenko
+ PDF Chat	Practical designs for Phase I combination studies in oncology	2015	Nolan A. Wages Anastasia Ivanova Olga Marchenko
+ PDF Chat	Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice	2004	Wendy R. Parulekar Elizabeth A. Eisenhauer
+	Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents	2009	Shenghua Kelly Fan Alan P. Venook Ying Lü
+	Dose Finding for a Combination of Two Agents	2018	Akihiro Hirakawa Hiroyuki Sato Takashi Daimon Shigeyuki Matsui
+	Phase I Oncology Research	2008	Manish Agrawal Ezekiel J. Emanuel
+	Optimal Biological Dose and Phase I/II Trials	2023	Haitao Pan Ying Yuan
+ PDF Chat	An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics	2010	Patricia LoRusso Scott A. Boerner Lesley Seymour
+ PDF Chat	Phase I Cancer Clinical Trials	2015
+ PDF Chat	Phase I Clinical Trials in Oncology	2020	Prasanth Ganesan
+	Oncology Combination Drug Development Strategies for Project Optimus	2024	Timothy A. Yap Julie Bullock S F Chong Megan K. Doyle Azher Hussain J. Jude Kline Amandine Manon Karthik Venkatakrishnan Vijay Upreti

Works That Cite This (0)

Action	Title	Year	Authors

Works Cited by This (3)

Action	Title	Year	Authors
+	Using the tolerable-dose diagram in the design of phase I combination chemotherapy trials.	1993	Edward L. Korn Ronald Simon
+	A Parallel Phase I/II Clinical Trial Design for Combination Therapies	2006	Xuelin Huang Swati Biswas Yasuhiro Oki Jean–Pierre J. Issa Donald A. Berry
+	Phase I Cancer Clinical Trials: A Practical Guide	2006	Elizabeth A. Eisenhauer Christopher Twelves Marc Buyse